Simvastatin causes changes in affective processes in elderly volunteers

Journal of the American Geriatrics Society

Volumn 54, Issue 1, 2006, Pages 70-76

  Morales, Knashawn ^a   Wittink, Marsha ^a   Datto, Catherine ^a,b   Difilippo, Suzanne ^a,b   Cary, Mark ^a   Tenhave, Thomas ^a,b   Katz, Ira R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Affect; Cholesterol; Depression; Diaries; Simvastatin

Indexed keywords

CHOLESTEROL; PLACEBO; SIMVASTATIN;

AFFECT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; ELDERLY CARE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PAIN; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VOLUNTEER;

AFFECT; AGED; CHOLESTEROL; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; REFERENCE VALUES; SELF ASSESSMENT (PSYCHOLOGY); SIMVASTATIN;

EID: 33645130549     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.00542.x     Document Type: Article

References (50)

1. Grundy SM Cleeman JI Merz CN et al Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 2004 110 227 239
2. Engleberg H. Low serum cholesterol and suicide Lancet 1992 339 727 729
3. Muldoon MF Manuck SB. Ischemic heart disease and cholesterol. Safety of cholesterol reduction remains in doubt BMJ 1994 308 1104 1105
4. Muldoon M. Injury, death and cholesterol Ann Intern Med 1994 121 719 720
5. Ryman A. Cholesterol, violent death, and mental disorder BMJ 1994 309 421 422
6. Brown SM Salive ME Harris TB et al Low cholesterol concentrations and severe depressive symptoms in elderly people BMJ 1994 308 1328 1332
7. McCallum J Simons L Simons J et al Low serum cholesterol is not associated with depression in the elderly Data from an Australian community study Aust N Z J Med 1994 24 561 564
8. Boston P Drusun S Reveley MA. Cholesterol and mental disorder Br J Psychiatry 1996 169 682 689
9. Steegmans P Hoes A Bak AA et al Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels Psychosom Med 2000 62 205 211
10. Steegmans P Fekkes D Hoes AW et al Low serum cholesterol concentrations and serotonin metabolism in men BMJ 1996 312 221
11. Law M Thompson S Wald MJ. Assessing possible hazards of reducing serum cholesterol BMJ 1994 308 373 379
12. Lindberg G Hallas J. Cholesterol-lowing drugs and antidepressants - a study of prescription symmetry Pharmacoepidemiol Drug Saf 1998 7 399 402
13. Boumendil E Tubert-Bitter P. Depression-induced absenteeism in relation to antihyperlipidemic treatment A study using GAZEL cohort data Epidemiology 1995 6 322 325
14. Stewart R Sharples K North FM et al Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin Arch Intern Med 2000 160 2129 2134
15. Dujovne CJ Chremos AN Pool JL et al Expanded Clinical Evaluation of Lovastatin (EXCEL) study results, IV. Additional perspectives on the tolerability of lovastatin Am J Med 1991 91 Suppl B 25S 30S
16. Downs J Oster G Santanello NC. HMG CoA reductase inhibitors and quality of life JAMA 1993 269 3107 3108
17. Muldoon MF Barger SD Ryan CN et al Effects of lovastatin on cognitive function and psychological well being Am J Med 2000 108 538 546
18. Hyyppa MT Kronholm E Virtanen A et al Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial Psychoneuroendocrinology 2003 28 181 194
19. Young-Xu Y Chan KA Liao JK et al Long-term statin use and psychological well-being J Am Coll Cardiol 2003 42 690 697
20. Lett HS Blumenthal JA Babyak MA et al Depression as a risk factor for coronary artery disease. Evidence, mechanisms, and treatment Psychosom Med 2004 66 305 315
21. Pratt LA Ford DE Crum RM et al Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up Circulation 1996 94 3123 3129
22. Ariyo AA Haan M Tangen CM et al Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans Circulation 2000 102 1773 1779
23. Winter L Lawton MP Casten RJ et al The relationship between external events and affect states in older people Int J Aging Hum Dev 2000 50 85 96
24. Lawton MP Winter L Kleban MH et al Affect and quality of life Objective and subjective J Aging Health 1999 11 169 198
25. Lawton MP De Voe MR Parmelee P. Relationship of events and affect in the daily life of an elderly population Psychol Aging 1995 10 469 477
26. Lawton MP Kleban MH Dean J. Affect and age. Cross-sectional comparisons of structure and prevalence Psychol Aging 1993 8 165 175
27. Lawton MP Kleban MH Rajagopal D et al Dimensions of affective experience in three age groups Psychol Aging 1992 7 171 184
28. Kleban MH Lawton MP Nesselroade JR et al The structure of variation in affect among depressed and nondepressed elders J Gerontol 1992 47 P190 P198
29. Lawton MP Kleban MH Dean J et al The factorial generality of brief positive and negative affect measures J Gerontol 1992 47 P228 P237
30. Lawton MP DeVoe MR Parmelee P. Relationship of events and affect in the daily life of an elderly population Psychol Aging 1995 10 469 477
31. Lawton MP Parmelee PA Katz IR et al Affective states in normal and depressed older people J Gerontol B Psychol Sci Soc Sci 1996 51B P309 P316
32. Radloff LS. The CES-D Scale A self-report depression scale for research in the general population Appl Psychol Meas 1997 1 385 401
33. First MB Spitzer RL Gibbon M et al Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version Washington, DC American Psychiatric Press 1997
34. McNair DM Lorr M Droppleman LF. Profile of Mood States (POMS) San Diego, CA Edits/Educational and Industrial Testing Service 1981
35. Marin RS Biedrzycki RC Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale Psychiatry Res 1991 38 143 162
36. Katz IR Morales K Datto C et al Probing for affective side effects of drugs used in geriatric practice: Use of daily diaries to test for effects of metoclopramide and naproxen. Neuropsychopharmacology 2005 Apr 27; [Epub ahead of print].
37. Furlan PM Kallan MJ TenHave T et al SSRIs do not cause affective blunting in healthy elderly volunteers Am J Geriatr Psychiatry 2004 12 323 330
38. Schwartz JE Stone AA. Strategies for analyzing ecological momentary assessment data Health Psychol 1998 17 6 16
39. Stone AA ed. The Science of Self-Report Mahwah, NJ Lawrence Erlbaum Associates 2000
40. Stone AA Shiffman S Schwartz JE et al Patient compliance with paper and electronic diaries Control Clin Trials 2003 24 182 199
41. Cella D Bullinger M Scott C et al Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life Mayo Clin Proc 2002 77 384 392
42. Jacobs D Blackburn H Higgins M et al Report of the conference on low blood cholesterol Mortality associations Circulation 1992 86 1046 1060
43. Bjorkhem I Meaney S. Brain cholesterol Long secret life behind a barrier Arterioscler Thromb Vasc Biol 2004 24 806 815
44. Locatelli S Lutjohann D Schmidt HH-J et al Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia Evidence that simvastatin affects cholesterol metabolism in the human brain Arch Neurol 2002 59 213 216
45. Lutjohann D Stroick M Bertsch T et al High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs Steroids 2004 69 431 438
46. Bonetti PO Lerman LO Napoli C et al Statin effects beyond lipid lowering - are they clinically relevant? Eur Heart J 2003 24 225 248
47. Stancu C Sima A. Statins Mechanism of action and effects J Cell Mol Med 2001 5 378 387
48. Laufs U. Beyond lipid-lowering Effects of statins on endothelial nitric oxide Eur J Clin Pharmacol 2003 58 719 731
49. Wierzbicki AS Poston R Ferro A. The lipid and non-lipid effects of statins Pharmacol Ther 2003 99 95 112
50. Hamelin BA Turgeon J. Hydrophilicity/lipophilicity. Relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors Trends Pharmacol Sci 1998 19 26 37